Callahan Advisors’s Xylem XYL Stock Holding History
Bought
Maintained
Sold
Other funds holding XYL
AAIS
RS
DC
Callahan Advisors's XYL Position: Q2 2026 in Review
Callahan Advisors reduced its Xylem (XYL) stake by 12% in Q2 2026, selling an estimated $206K and leaving 12,801 shares worth $1.51M. The position accounts for 0.11% of the portfolio, ranked #104.
Callahan Advisors first reported a position in XYL in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.74M in Q1 2026. 456 funds tracked by Wall St. Rank hold XYL as of Q2 2026.
- Callahan Advisors held 12,801 shares of Xylem worth $1.51M as of Q2 2026.
- Callahan Advisors sold 1,782 Xylem shares in Q2 2026, an estimated $206K.
- Xylem made up 0.11% of Callahan Advisors's portfolio in Q2 2026, its #104 holding.
- Callahan Advisors first reported a position in Xylem in Q4 2025 and has held it in 3 quarters since.
- Callahan Advisors's Xylem position peaked at $1.74M in Q1 2026.
- 456 funds tracked by Wall St. Rank held Xylem as of Q2 2026.
Based on Callahan Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.